Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40459946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP089016(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0613156Aexternal-prioritypatent/GB0613156D0/en
Priority claimed from GB0613158Aexternal-prioritypatent/GB0613158D0/en
Priority claimed from GB0613160Aexternal-prioritypatent/GB0613160D0/en
Priority claimed from GB0613159Aexternal-prioritypatent/GB0613159D0/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of ECSP089016ApublicationCriticalpatent/ECSP089016A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a compuestos de la fórmula (I) en forma de sal o solvato, en donde W, Rx, Ry, R1, R2, R3, R4, R5, R6 y R7, y A tienen los significados que se indican en la descripción, que son útiles para el tratamiento de enfermedades mediadas por el adrenorreceptor 2. También se describen composiciones farmacéuticas que contienen los compuestos y procesos para preparar dichos compuestos.The present invention relates to compounds of the formula (I) in the form of salt or solvate, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7, and A have the meanings indicated in the description, which are useful for the treatment of diseases mediated by the adrenoceptor 2. Pharmaceutical compositions containing the compounds and processes for preparing said compounds are also described.
ECSP0890162006-06-302008-12-29
DERIVATIVES OF QUINOLINA AND ITS PHARMACEUTICAL COMPOSITIONS
ECSP089016A
(en)
DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES
Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.
SUBSTITUTED DERIVATIVES OF N- (3,4-DIHIDRO-2H-CROMEN-3-IL) FORMAMIDA AND N- (1, 2,3, 4-TETRAHIDRONAFTALEN-2-IL) FORMAMIDA, SALTS OF THE SAME, COMPOSITIONS THAT CONTAIN THEM , PROCEDURES FOR PREPARATION AND APPLICATIONS